{"organizations": [], "uuid": "067da7f5cf0beec7e2a8cb84f04fc2243b851f4b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biocryst-reports-q4-loss-per-share/brief-biocryst-reports-q4-loss-per-share-of-0-20-idUSASB0C7PP", "country": "US", "domain_rank": 408, "title": "BRIEF-Biocryst Reports Q4 Loss Per Share of $0.20", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.003, "site_type": "news", "published": "2018-02-27T21:44:00.000+02:00", "replies_count": 0, "uuid": "067da7f5cf0beec7e2a8cb84f04fc2243b851f4b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biocryst-reports-q4-loss-per-share/brief-biocryst-reports-q4-loss-per-share-of-0-20-idUSASB0C7PP", "ord_in_thread": 0, "title": "BRIEF-Biocryst Reports Q4 Loss Per Share of $0.20", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biocryst pharmaceuticals inc", "sentiment": "negative"}, {"name": "dec", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Biocryst Pharmaceuticals Inc:\n* BIOCRYST REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.20 * Q4 REVENUE $3.9 MILLION VERSUS $9.0 MILLION * CASH, CASH EQUIVALENTS & INVESTMENTS TOTALED $159.0 MILLION AT DEC 31, 2017, REFLECTS INCREASE FROM $65.1 MILLION AT DEC 31, 2016\n* EXPECTS ITS 2018 NET OPERATING CASH USE TO BE IN RANGE OF $67 TO $90 MILLION\n* SEES 2018 OPERATING EXPENSES TO BE IN RANGE OF $85 TO $110 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T21:44:00.000+02:00", "crawled": "2018-02-28T12:47:50.000+02:00", "highlightTitle": ""}